A comprehensive protocol for management of cancer of the bilharzial bladder.
A randomized clinical trial for the management of bilharzial bladder cancer is presented. A multidisciplinary approach is adopted. The objective of the study is to evaluate the role of adjuvant radiotherapy in improving the results of surgery in deeply infiltrating tumours, and to screen a number of chemotherapeutic agents for their effectiveness in bladder cancer. A large number of cases will be admitted into the study and the results will hopefully help to achieve better results in the management of this disease.
D006585:Altretamine / Q000627:therapeutic use; D006801:Humans; D012552:Schistosomiasis / Q000150:complications*; D013713:Teniposide / Q000627:therapeutic use; D001745:Urinary Bladder Diseases / Q000150:complications*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*
D013713:Teniposide; D006585:Altretamine